期刊文献+

心力衰竭患者血清脑钠素测定及其意义 被引量:20

Study on the Clinical Significance of Determination of Serum Brain Natriuretic Peptide (BNP) Levels in Patients with Heart Failure
下载PDF
导出
摘要 目的 :探讨心力衰竭 (HF)患者血清脑钠素改变及其意义。方法 :放射免疫分析测定 88例HF(NYHAⅡ -Ⅳ级 )患者、2 0例心功能代偿期对照组 (NYHAⅠ级 )和 30例健康对照组的血清脑钠素水平 ,并进行对照分析。结果 :HF组总体血清脑钠素水平显著高于心功能处代偿期 (NYHAⅠ级 )组 (t=2 1 33,p <0 0 5 )和对照组 (t=2 335 ,p<0 0 5 ) ,NYHAⅡ级心功能时血BNP即显著高于对照组 (p <0 0 5 ) ,Ⅱ、Ⅲ、Ⅳ级组间血清BNP依次递增 (F =2 5 95 ,p<0 0 5 )。急性左心衰组血清BNP显著高于慢性心衰组 (t =2 2 6 8,p <0 0 5 ) ,而且缓解时血清BNP即显著下降 (p <0 0 5 )。结论 :测定血清脑钠素水平有助于HF患者发病机理、病情严重程度和预后的判断。 Objective To study the clinical significance of the changes of serum BNP levels in patients with heart failure (HF). Methods Serum BNP levels in 88 patients with HF(NYHAⅡ-Ⅳ), 20 patients with compensated cardiac function (NYHA Ⅰ) and 30 controls were determined with RIA. Results The serum BNP levels in patients with HF (264±63 9pmol/L) were significantly higher than those in patietns with compensated cardiac function (NYHA Ⅰ, 11 6±4 7pmol/L, t=2 133,p <0 05) and controls (7 6±4 1pmol/L, t=2 335,p <0 05). were no significant differences between the levels in NYHA Ⅰ subjects and controls ( t=0 883,p >0 05). As the cardiac function deteriorated from NYHAⅡ to NYHAⅣ, the BNP levels increased consecutively with significant differences from each other ( F=2 595,p <0 05). BNP levels in patients with acute left heart failure were significantly higher than those in patients with chronic heart failure ( t=2 268,p <0 05) and fell promptly at relief of the attacek ( p <0 05). Conclusion Determination of serum BNP levels in patietns with HF was helpful to the study of the severity and prognosis of the disease.
出处 《放射免疫学杂志》 CAS 2004年第1期15-16,共2页 Journal of Radioimmanology
关键词 心力衰竭 血清 脑钠素 预后 发病机理 放射免疫分析 Heart Failure, Brain Natriuretic Peptide, Radioimmunoassay
  • 相关文献

参考文献2

二级参考文献22

  • 1[1]Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000,93(1~2): 19-25.
  • 2[2]Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med, 1990,323: 757-758.
  • 3[3]Raine A E G, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med, 1986,315: 533-537.
  • 4[4]Yoshimura M, Yasue H, Okumura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993,87: 464-469.
  • 5[5]Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994,90: 195-203.
  • 6[6]Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92: 1558-1564.
  • 7[7]Arakawa N, Nakamura M, Aoki H, et al. Relati-onship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology, 1994,85:334-340.
  • 8Ishii J, Nomura M, Nakamura Y, et al. Risk Stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol,2002, 89 : 691--695.
  • 9Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med, 1998, 339:321--328.
  • 10Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (NBNP) concentrations. The Lancet, 2000, 355:1126--1130.

共引文献63

同被引文献108

引证文献20

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部